is januvia a semaglutide Merck diabetes drug gets CV trial boost Cardiovascular Outcomes With Merck's Januvia:

GHKCu enhances antioxidant enzyme expression and reduces lipid peroxidation and oxidative DNA damage in preclinical tissue repair models (17,18)

doi: 10.2174/1389200223666220328143828

Risk factors that warrant particular caution include: Severe intercurrent illness or major surgery Significant reduction or cessation of insulin therapy Prolonged fasting or very low carbohydrate intake Excessive alcohol consumption Undiagnosed type 1 diabetes or LADA Concomitant use of SGLT2 inhibitors The MHRA and EMA product information for Mounjaro does not list DKA as a common adverse effect, and large clinical trials have not demonstrated an increased incidence compared to placebo or active comparators

Sarcopenia, the age-related loss of muscle mass and strength, is a significant health concern that can have far-reaching consequences

5 Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study